Heterocyclic compounds and uses thereof
JL Kutok, DG Winkler, VJ Palombella - US Patent 10,675,286, 2020 - Google Patents
2017-11-17 Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Heterocyclic compounds and uses thereof
AC Castro, K Chan, CA Evans… - US Patent …, 2015 - Google Patents
2013-07-03 Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Heterocyclic compounds and uses thereof
JL Kutok, DG Winkler, VJ Palombella… - US Patent …, 2017 - Google Patents
2015-06-30 Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Efficacious inhaled PDE4 inhibitors with low emetic potential and long duration of action for the treatment of COPD
Oral phosphodiesterase 4 (PDE4) inhibitors, such as cilomilast and roflumilast, have been
shown to be efficacious against chronic obstructive pulmonary disease (COPD). However …
shown to be efficacious against chronic obstructive pulmonary disease (COPD). However …
Heterocyclic compounds and uses thereof
AC Castro, CA Evans, S Janardanannair… - US Patent …, 2017 - Google Patents
2015-08-06 Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Heterocyclic compounds and uses thereof
AC Castro, CA Evans, S Janardanannair… - US Patent …, 2016 - Google Patents
2015-04-23 Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Heterocyclic compounds and uses thereof
AC Castro, K Chan, CA Evans… - US Patent …, 2016 - Google Patents
2015-04-03 Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
Heterocyclic compounds and uses thereof
AC Castro, S Janardanannair, CA Evans… - 2022 - Google Patents
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo [4, 3-d]
pyrimidin-5-yl]-3-methyl-3, 8-diazabicyclo [3.2. 1] octan-2-one Chemical class C1 (CC1) …
pyrimidin-5-yl]-3-methyl-3, 8-diazabicyclo [3.2. 1] octan-2-one Chemical class C1 (CC1) …
2, 4, 8-trisubstituted-8H-pyrido [2, 3-d] pyrimidin-7-one compounds and compositions for use in therapy
JL Adams, JC Boehm, R Hall, Q Jin, J Kasparec… - US Patent …, 2011 - Google Patents
US8058282B2 - 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and
compositions for use in therapy - Google Patents US8058282B2 - 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one …
compositions for use in therapy - Google Patents US8058282B2 - 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one …
Heterocyclic compounds and uses thereof
AC Castro, CA Evans, S Janardanannair… - US Patent …, 2017 - Google Patents
2016-08-25 Assigned to INFINITY PHARMACEUTICALS, INC. reassignment INFINITY
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …
PHARMACEUTICALS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …